Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 6—June 2016
Dispatch

MERS-CoV Antibodies in Humans, Africa, 2013–2014

Anne M. Liljander1, Benjamin Meyer1, Joerg Jores, Marcel A. Müller, Erik Lattwein, Ian Njeru, Bernard Bett, Christian DrostenComments to Author , and Victor Max Corman
Author affiliations: International Livestock Research Institute, Nairobi, Kenya (A. Liljander, J. Jores, B. Bett); University of Bonn Medical Centre, Bonn, Germany (B. Meyer, M.A. Müller, C. Drosten, V.M. Corman); University of Bern, Vetsuisse Faculty, Bern, Switzerland (J. Jores); EUROIMMUN AG, Lübeck, Germany (E. Lattwein); Ministry of Health, Nairobi, Kenya (I. Njeru); German Centre for Infection Research, Bonn (C. Drosten, V.M. Corman)

Main Article

Figure 1

Plot of all individual optical density (OD) ratios obtained from recombinant ELISA testing of human serum samples for Middle East respiratory syndrome coronavirus (MERS-CoV) antibodies, Africa, 2013–2014. All 16 samples exceeding the cutoff of 0.3 and 22 other samples showing an OD ratio below the cutoff were subsequently tested in a plaque-reduction virus neutralization (PRNT) test; these samples are shown in blue, and the 2 samples positive by PRNT are shown in red. The horizontal dashed line

Figure 1. Plot of all individual optical density (OD) ratios obtained from recombinant ELISA testing of human serum samples for Middle East respiratory syndrome coronavirus (MERS-CoV) antibodies, Africa, 2013–2014. All 16 samples exceeding the cutoff of 0.3 and 22 other samples showing an OD ratio below the cutoff were subsequently tested in a plaque-reduction virus neutralization (PRNT) test; these samples are shown in blue, and the 2 samples positive by PRNT are shown in red. The horizontal dashed line represents the cutoff value as determined in a nationwide, cross-sectional serologic study in Saudi Arabia (6).

Main Article

References
  1. Mackay  IM, Arden  KE. MERS coronavirus: diagnostics, epidemiology and transmission. Virol J. 2015;12:222. DOIPubMedGoogle Scholar
  2. Haagmans  BL, Al Dhahiry  SH, Reusken  CB, Raj  VS, Galiano  M, Myers  R, Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis. 2014;14:140–5. DOIPubMedGoogle Scholar
  3. Alraddadi  BM, Watson  JT, Almarashi  A, Abedi  GR, Turkistani  A, Sadran  M, Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. Emerg Infect Dis. 2016;22:49–55. DOIPubMedGoogle Scholar
  4. Gossner  C, Danielson  N, Gervelmeyer  A, Berthe  F, Faye  B, Kaasik Aaslav  K, Human–dromedary camel interactions and the risk of acquiring zoonotic Middle East respiratory syndrome coronavirus Infection. Zoonoses Public Health. 2016;63:1–9 . DOIPubMedGoogle Scholar
  5. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV)—Saudi Arabia [cited 2016 Jan 4]. http://www.who.int/csr/don/4-january-2016-mers-saudi-arabia/en/
  6. Müller  MA, Meyer  B, Corman  VM, Al-Masri  M, Turkestani  A, Ritz  D, Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis. 2015;15:559–64. DOIPubMedGoogle Scholar
  7. Corman  VM, Jores  J, Meyer  B, Younan  M, Liljander  A, Said  MY, Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992–2013. Emerg Infect Dis. 2014;20:1319–22. DOIPubMedGoogle Scholar
  8. Müller  MA, Corman  VM, Jores  J, Meyer  B, Younan  M, Liljander  A, MERS coronavirus neutralizing antibodies in camels, eastern Africa, 1983–1997. Emerg Infect Dis. 2014;20:2093–5. DOIPubMedGoogle Scholar
  9. Chu  DK, Oladipo  JO, Perera  RA, Kuranga  SA, Chan  SM, Poon  LL, Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015. [PubMed ]. Euro Surveill. 2015;20:30086. DOIPubMedGoogle Scholar
  10. Chu  DK, Poon  LL, Gomaa  MM, Shehata  MM, Perera  RA, Abu Zeid  D, MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis. 2014;20:1049–53. DOIPubMedGoogle Scholar
  11. Jores  J. Middle East respiratory syndrome-coronavirus in camels: an overview for Sub-Saharan and North Africa. Evidence on Demand, UK. 2015.
  12. Drosten  C, Meyer  B, Muller  MA, Corman  VM, Al-Masri  M, Hossain  R, Transmission of MERS-coronavirus in household contacts. N Engl J Med. 2014;371:828–35. DOIPubMedGoogle Scholar
  13. World Health Organization. Laboratory testing for Middle East respiratory syndrome coronavirus [cited 2015 Jun 30]. http://apps.who.int/iris/bitstream/10665/176982/1/WHO_MERS_LAB_15.1_eng.pdf
  14. Park  SW, Perera  RA, Choe  PG, Lau  EH, Choi  SJ, Chun  JY, Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection. Euro Surveill. 2015;20:30042. DOIPubMedGoogle Scholar
  15. Eckerle  I, Corman  VM, Muller  MA, Lenk  M, Ulrich  RG, Drosten  C. Replicative capacity of MERS coronavirus in livestock cell lines. Emerg Infect Dis. 2014;20:276–9. DOIPubMedGoogle Scholar

Main Article

1These authors contributed equally to this article.

Page created: May 16, 2016
Page updated: May 16, 2016
Page reviewed: May 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external